...

Prostate Cancer

What Is the Best Treatment for Prostate Cancer in Early Stages

What Is the Best Treatment for Prostate Cancer in Early Stages?

Quick Summaryr Early-stage prostate cancer treatment options include active surveillance (low-risk), surgery (radical prostatectomy), radiation therapy (external beam or brachytherapy), and focal therapies (targets only affected areas). Choice depends on cancer stage, PSA levels, tumor type, and patient health. Regular follow-up with PSA tests and imaging ensures long-term cancer control.

Read More »
How Prostate Cancer Progresses-From Local to Metastatic

How Prostate Cancer Progresses: From Local to Metastatic

Quick Read Summary Prostate cancer can start in the prostate and progress locally or metastatically. Early stages often stay in the gland, while advanced types spread to lymph nodes or bones. PSA tests, imaging, and biopsies help track progression. Stages guide treatment: Stage I–II usually remains inside the prostate, Stage

Read More »
Types of Prostate Cancer and How They Differ

Types of Prostate Cancer and How They Differ

Summary Prostate cancer includes several types that differ in how fast they grow, how aggressive they act, and how doctors treat them. Knowing these differences helps patients understand PSA results, Gleason scores, treatment choices, and long-term outlook. Most Common Type: Acinar adenocarcinoma makes up over 90% of prostate cancers. More

Read More »
Debunking Common Myths About Prostate Cance

Debunking Common Myths About Prostate Cancer

Summary Prostate cancer ranks as one of the most common cancers in men. However, many myths surround it. This guide clears up misconceptions to help you understand the facts and make informed decisions about your health. Myth 1: Only Older Men Get Prostate Cancer – Although age plays a significant

Read More »
The Role of Immunotherapy in Prostate Cancer Treatment

The Role of Immunotherapy in Prostate Cancer Treatment

Quick Summery Understanding the role of immunotherapy in prostate cancer treatment is increasingly important as more men explore advanced care options. Immunotherapy strengthens the body’s immune system so it can better detect and destroy prostate cancer cells, offering new hope for patients whose tumors no longer respond to standard hormone

Read More »
Difference Between Benign Prostate Enlargement and Cancer

Difference Between Benign Prostate Enlargement and Cancer

Quick Summmery Understanding the Difference Between Benign Prostate Enlargement and Cancer is essential for men over 50. Both conditions can cause similar urinary symptoms, but they occur for very different reasons. This guide explains how BPH compares to prostate cancer, which symptoms matter most, and why early tests such as

Read More »

What Happens After an Abnormal PSA Test?

What Happens After an Abnormal PSA Test? An abnormal PSA test can be concerning, but it does not necessarily indicate prostate cancer. Elevated PSA levels can have multiple causes, including benign conditions like BPH or prostatitis. Further diagnostic steps are essential to determine the cause. PSA test measures prostate-specific antigen

Read More »
Genetic Risk Factors for Prostate Cancer in Malaysian Men

Genetic Risk Factors for Prostate Cancer in Malaysian Men

Quick Read Summary Genetic factors play a significant role in prostate cancer risk, especially for Malaysian men. Family history, inherited gene mutations (like BRCA1, BRCA2, HOXB13), and ethnic-specific variations can increase susceptibility. Understanding these risks enables early detection through regular screening, genetic counseling, and proactive lifestyle choices, improving outcomes and

Read More »
Early Signs of Prostate Cancer You Shouldn’t Ignore

Early Signs of Prostate Cancer You Shouldn’t Ignore

Quick Read Summary Early signs of prostate cancer often appear gradually and can be easy to overlook. Recognizing changes in urinary habits, discomfort in the lower back or pelvis, and unexpected weight loss helps men get timely checkups. Early detection through exams like digital rectal exams (DRE) and PSA blood

Read More »
How real-world evidence is empowering treatment decisions in prostate cancer

How Real‑World Evidence Is Transforming Prostate Cancer Treatment Decisions

Quick Read Summary This article explores how real-world evidence (RWE) is transforming prostate cancer treatment, complementing traditional randomized controlled trials (RCTs). It discusses a major observational study comparing apalutamide and enzalutamide in metastatic castration-sensitive prostate cancer (mCSPC), showing a 23% lower mortality risk with apalutamide at 24 months. The piece

Read More »

免费下载有关膀胱癌的手册

Download our booklet

Download our booklet